ARQT - Jones Research downgrades Arcutis to hold cites loan agreement
2023-11-08 13:31:15 ET
More on Arcutis Biotherapeutics
- Arcutis Biotherapeutics, Inc. (ARQT) Q3 2023 Earnings Call Transcript
- Arcutis Biotherapeutics, Inc. 2023 Q3 - Results - Earnings Call Presentation
- Mizuho cuts Articus to neutral, cites lower-than-expected prescriptions
- Arcutis announces pricing of $100 million public offering
- Seeking Alpha’s Quant Rating on Arcutis Biotherapeutics
For further details see:
Jones Research downgrades Arcutis to hold, cites loan agreement